Monday, September 15, 2025

Latest

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE: MCUR) this morning effectively announced it will be turning itself into a shell. The move follows a strategic review conducted by the company.

The strategic review is said to be done just its initial phases of the process, which included “an extensive canvas of various strategic alternatives available.” The review however has indicated that the company simply does not have the funds to execute its current strategy, and that the current environment is unlikely to provide the capital required to move forward. In simple terms, tailwinds have exited the psychedelic and psychedelic-adjacent sector, with investors unwilling to provide further capital to support the space.

As a result of the findings, the company has identified that “none of the strategic alternatives available to the company necessitated ongoing developmental expenditures.”

As such, the company has decided that it needs to cut all expenditures, as a means of “preserving the value” of the firms assets – which appears to largely be a reference to its cash position and public company status rather than anything else. To do so, the board has fired the entire C-Suite, save for its CFO, as well as the entire workforce, save for the VP of engineering and certain admin staff needed to wind down operations.

More specifically, all R&D on its ibogaine program and Desire Project are to be halted, as well as all non-committed expenditures related to iSTRYM.

The company reported that as of yesterday it had $10.57 million in cash on hand, before any liabilities are considered, which may include termination payouts for the staff eliminated as a result of this mornings decision.

With the departure of the C-suite, the firms chairman, Philip Tapley, has been named as interim CEO of the company.

Mind Cure Health last traded at $0.075 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Mind Cure Signs LOI To Take Equity Stake In Psychedelic Treatment Centre

Mind Cure Health (CSE: MCUR) has signed a non-binding letter of intent to conduct a...

Tuesday, January 12, 2021, 07:41:53 AM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM

Mind Cure Announces $10.0 Million Bought Deal Financing

Mind Cure Health (CSE: MCUR) this afternoon revealed that it is conducting a bought deal...

Thursday, January 21, 2021, 04:01:29 PM

Mind Cure Enters LOI To Acquire Ephiphany360 Digital Therapeutics Platform

Mind Cure Health (CSE: MCUR) is getting into the digital therapeutics space. The company announced...

Wednesday, October 21, 2020, 08:47:34 AM

Mind Cure Closes Acquisition Deal, To Be Renamed LNG Energy

Mind Cure Health Inc. (CSE: MCUR) has closed the previously announced business combination with LNG...

Wednesday, August 16, 2023, 09:38:44 AM